**Question:** Which one of the following treatments is effective in primary biliary cirrhosis?

A. Azathioprine
B. Ursodeoxycholic acid
C. Methotrexate
D. None of the above

**Core Concept:** Primary biliary cirrhosis (PBC) is a chronic liver disease characterized by the destruction of small bile ducts, leading to inflammation, fibrosis, and ultimately liver cirrhosis. The treatment options aim to manage symptoms, improve liver function, and prevent disease progression.

**Why the Correct Answer is Right:** Azathioprine (Imuran) is an immunosuppressive agent that works by inhibiting the activation of lymphocytes and reducing inflammation. As PBC is a chronic autoimmune liver disease, immunosuppressive therapy can be beneficial in managing the disease progression and preventing cirrhosis.

**Why Each Wrong Option is Incorrect:**

B. Ursodeoxycholic acid (Ursodiol) is a bile acid that helps improve liver function in PBC patients by reducing inflammation and promoting bile flow. It is a supportive treatment, not directly targeting the immune system or preventing disease progression.

C. Methotrexate (MTX) is an immunosuppressive agent typically used in rheumatoid arthritis and certain cancers. However, it has not been proven to be effective in PBC and may even increase the risk of liver toxicity.

D. None of the above (option D) is incorrect because both azathioprine and ursodeoxycholic acid have been proven to be effective in managing PBC symptoms and improving liver function. Methotrexate is not suitable for PBC treatment, and therefore, none of the above options is correct in addressing the primary treatment of PBC.

**Clinical Pearl:** Ursodeoxycholic acid (Ursodiol) is a cornerstone treatment for primary biliary cirrhosis (PBC). It helps to improve liver function by reducing inflammation and promoting bile flow, but it does not directly address the autoimmune component of the disease. Azathioprine (Imuran) is an immunosuppressive agent that can be beneficial in controlling the disease progression and preventing cirrhosis. Methotrexate is not a suitable treatment for PBC, as it is not specifically targeted at addressing the autoimmune aspect of the disease. Therefore, option D is incorrect, and only azathioprine and ursodeoxycholic acid are appropriate treatments for primary biliary cirrhosis.

**Correct Answer:**

A. Azathioprine (Imuran)

**Explanation:**

Azathioprine is an immunosuppressive agent that helps to reduce inflammation and suppress the immune response in PBC patients. By addressing the autoimmune component of the disease, azathioprine can help control the progression of the disease and prevent liver cirrhosis. Ursodeoxycholic acid (Ursodiol) and azathioprine are the appropriate treatments for primary biliary cirrhosis, as they address the autoimmune aspect of the disease. Methotrexate is not suitable for PBC treatment, as it is not specifically targeted at addressing the autoimmune aspect of the disease.